Overview

Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
A study to assess the safety and efficacy of moxifloxacin compared to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbation of chronic bronchitis.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Clavulanic Acid
Clavulanic Acids
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination